Publications

H-index: 12 (according to the ISI Thompson Web of Knowledge database as well as the Scopus Elsevier database)
Total Impact Factor: 180,03

  1. Baritussio A., Marzini S., Agostini M., Alberti A., Cimenti C, Brutomesso D, Manzato E, Quaglino D., Petenazzo A. Amiodarone inhibits lung degradazion of SP-A and perturbs the distribution of lysosomal enzymes. Am J Physiol Lung Cell Mol Physiol. 2001; 281(5):L1189-99
  2. Pucciarelli S, Agostini M, Viel A, Bertorelle R, Russo MV, Toppan P, Lise M. Early onset of colorectal cancer and microsatellite instability as markers of hereditary non-polyposis colon cancer (HNPCC). Dis Colon Rectum. 2003; 46(3):305-12.
  3. Pasetto LM, Pucciarelli S, Agostini M, Rossi E, Monfardini S. Neoadjuvant Treatment for Locally Advanced Rectal Carcinoma. Crit Rev Oncol Hematol. 2004; 52(1):61-71.
  4. Agostini M, Pucciarelli S, Bertorelle R, Calandra P, Villani F, Lise M, Nitti D. Genetic heterogeneity of variable number tandem repeats in thymidylate synthase gene in colorectal cancer patients. Int J Biol Markers. 2004; 19(4):332-6.      
  5. Seraglia R, Ragazzi E, Vegliardi S, Allegri G, Pucciarelli S, Agostini M, Lise M, Traldi P. Search of plasma markers for colorectal cancer by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom. 2005; 40: 123- 126.
  6. Agostini M, Tibiletti Mg, Lucci-Cordisco E, Chiaravalli A, Morreau H, Furlan D, Boccuto L, Pucciarelli S, Capella C, Boiocchi M, Viel A. Two PMS2 mutations in a Turcot syndrome family with small bowel cancers. Am J Gastroenterol. 2005; 100(8):1886-91.
  7. Pastrello C, Baglioni S, Tibiletti MG, Papi L, Fornasarig M, Morabito A, Agostini M, Genuardi M, Viel A. Stability of BAT26 in tumours of hereditary non-polyposis colorectal cancer patients with MSH2 intragenic deletion. Eur J Hum Genet. 2006, 14; 63- 68.
  8. Pasetto LM, Friso ML, Pucciarelli S, Basso U, Toppan P, Agostini M, Rugge M, Serpentini S, Nitti, Monfardini S. Rectal cancer neoadjuvant treatment in elderly patients. Anticancer Res. 2006; 26(5B):3913-23.
  9. Mammano E, Belluco C,  Sciro M, Mencarelli R, Agostini M, Michelotto M, Marchet A, Nitti D, Lise M. Epidermal growth factor receptor (EGFR) mutational and protein expression analysis in gastric cancer. Anticancer Res. 2006; 26 :3547-50.
  10. Ragazzi E, Seraglia R, Pucciarelli S, Molin L, Agostini M, Lise M,  Traldi P,  Nitti D. Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer. J Mass Spectrom. 2006; 41(12):1546-53.
  11. Terrazzino S, Agostini M, Pucciarelli S, Pasetto LM, Friso ML, Ambrosi A,  Lisi V, Leon A, Lise M, Nitti D. A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation. Pharmacogenet Genomics. 2006; 16(11):817-24.
  12. Urso E, Pucciarelli S, Cassaro M, Agostini M, Nitti D. Early stage duodenal carcinoid treated by endoscopic forceps biopsies. Case report after 12 years follow up and review of literature on endoscopic treatments of duodenal neuroendocrine tumors. Endoscopy 2007; 39 Suppl 1:E128
  13. Pastrello C, Tricarico R, Tibiletti MG, Papi L, Fornasarig M, Morabito A, Agostini M, Genuardi M, Viel A. Reply to Jaskowski et Al. Eur J Hum Genet. 2007; 15(2):141-2.
  14. Pasetto Lm, Basso U, Friso Ml, Pucciarelli S, Agostini M, Rugge M, Sinigaglia G, Lise M, Sotti G, Monfardini S. Determining therapeutic approaches in the elderly with rectal cancer. Drugs Aging. 2007; 24(9):781-90.
  15. Seraglia R, Molin L,  Tonidande L, Pucciarelli S, Agostini M, Urso ED, Bedin C, Quaia M, Nitti D, Traldi P. An investigation on the nature of the peptide at m/z 904, overexpressed in plasma of patients with colorectal cancer and familial adenomatous polyposis. J Mass Spectrom. 2007; 42(12):1606-1612
  16. Urso E, Pucciarelli S, Agostini M, Maretto I, Mescoli C, Bertorelle R, Viel A, Rugge M, Nitti D. Proximal colon cancer in patients aged 51-60 years of age should be tested for microsatellites instability. A comment on the Revised Bethesda Guidelines. Int J Colorectal Dis. 2008; 23(8):801-6.
  17. Avezzù A, Agostini, Pucciarelli S, Lise M,Urso ED, Mammi I, Maretto I, Enzo MV, Lise M, Nitti D, Viel A. The role of myh gene in genetic predisposition to colorectal cancer: another little piece of the puzzle. Cancer Lett. 2008; 268: 308-13.
  18. Agostini M, Pasetto LM, Pucciarelli S, Terrazzino S, Ambrosi, Bedin C, Friso ML, Mescoli, Urso E, Leon A, Lise M, Nitti D. Glutathione S-transferase P1 Ile105Val polymorphism is associated with haematological toxicity in elderly rectal cancer patients receiving preoperative chemoradiotherapy. Drugs Aging. 2008; 25(6):531-9.
  19. Pasetto LM, Basso U, Sinigaglia G, Pucciarelli S, Friso ML, Rugge M, Toppan P, Agostini M, Monfardini S. Rectal cancer adjuvant chemotherapy: when is more useful? Anticancer Res. 2008; 28(3B):1805-12.
  20. Terrin L, Rampazzo E, Pucciarelli S, Agostini M, Bertorelle R, Esposito G, Del Bianco P, Nitti D, De Rossi A. Relationship between tumor and plasma levels of Telomerase Reverse Transcriptase mRNA in patients with colorectal cancer: implications for non-invasive monitoring of neoplastic disease. Clin Cancer Res. 2008 Nov 15;14(22):7444-51.
  21. Pasetto LM, Friso ML, Pucciarelli S, Basso U, Rugge M, Sinigaglia G, Rossi E,  Compostella A, Toppan P, Agostini M, Monfardini S.   Role of neoadjuvant treatment in cT3N0M0 rectal cancer. Anticancer Res. 2008;28(6B):4129-35.
  22. Pasetto LM, Sinigaglia G, Basso U, Cocchio S, Compostella A, Pucciarelli S, Friso ML, Rugge M, Toppan P, Agostini M, Monfardini S. Neoadjuvant chemoradiotherapy with 5-fluorouracil by bolus. Anticancer Res. 2008;28(6B):4095-100.
  23. Cristoni S, Molin L, Lai A,  Rossi Bernardi L, Pucciarelli S, Agostini M, Bedin C, Nitti D, Seraglia R, Repetto O, Dibari VF, Orlandi R, Traldi P. On the application of a new MALDI/MS-NIST library approach for colorectal cancer disease diagnosis.  Rapid Communications in Mass Spectrometry 2009; 23:2839-2845.
  24. Zancan M, Galdi F, Di Tonno F, Mazzariol C, Orlando C, Malentacchi F, Agostini M, Maran M, Del Bianco P, Fabricio A, Murer B, Pianon C, Gion M. Evalutation of cell-free DNA in urine as marker for bladder cancer diagnosis. The International Journal of Biological Markers. 2009, 3: 147-155.
  25. Agostini M, Enzo MV, Morandi L, Bedin C, Pizzini S, Mason S, Bertorelle R, Urso E, Mescoli C, Lise M, Pucciarelli S, Nitti D. A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors.  Cancer Biomarkers, 2010, 6: 49-61.
  26. Cecchin E, Agostini M, Pucciarelli S, De Paoli A, Canzonieri V, Sigon R, De Mattia E, Friso ML, Biason P, Visentin M, Nitti D, Toffoli G. The tumor response is predicted by the patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy. Pharmacogenomics J. 2010 Apr 6. [Epub ahead of print]
  27. Agostini M, Pucciarelli S, Calore F, Bedin C, Enzo MV, Nitti D. miRNAs in colon and rectal cancer: a consensus for their true clinical value. Clin Chim Acta. 2010 Sep 6;411(17-18):1181-6. Epub 2010 May 7. Review.
  28. Pastrello C, Pin E, Marroni F, Bedin C, Fornasarig M, Tibiletti MG, Oliani C, Ponz de Leon M, Urso E, Della Puppa L, Agostini M, Viel A. Integrated analysis of unclassified variants in mismatch repair genes. Genetics in Medicine. 2011 Jan 13. [Epub ahead of print]
  29. Nascimbeni R, Pucciarelli S, Di Lorenzo D, Urso E, Casella C, Agostini M, Nitti D, Salerni B. Rectum-Sparing Surgery May be Appropriate for Biallelic MutYH-Associated Polyposis. Disease and Colonrectum. 2010 Dec;53(12):1670-5.
  30. Agostini M, Pucciarelli S, Enzo MV, Del Bianco P, Briarava M, Bedin C, Maretto I, Friso ML, Lonardi S, Mescoli C, Toppan P, Urso E, Nitti D. Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy. Ann Surg Oncol. 2011 Mar 17. [Epub ahead of print]
  31. Agostini M, Bedin C, Pucciarelli S, Enzo MV, Briarava M, Seraglia R, Ragazzi E, Traldi P, Molin L, Urso ED, Mammi I, Viel A,Lise M, Tasciotti E, Biasolo A, Pontisso P, Nitti D. Forkhead box gene (FOXO1A) and colorectal tumors: another piece of an interesting correlation.  (in press)
  32. Marioni G, Agostini M, Bedin C, Blandamura S, Stellini E, Favero G, Lionello M, Giacomelli L, Burti S, D’Angelo E, Nitti D, Staffieri A, de Filippis C. Survivin and laryngeal carcinoma prognosis: nuclear localization and splice variants expression. (in press Histopatology)
  33. Urso E, Agostini M, Pucciarelli S, Rugge M, Bertorelle R, Maretto I, Bedin C, Mescoli C, Zorzi M, Viel A, Bruttocao G, Ferraro B, Erroi F, Contin P, De Salvo GL, Nitti D. Clinical and molecular detection of inherited colorectal cancers in Northeast Italy. A first prospective study of incidence of Lynch syndrome and MUTYH related colorectal cancer in Italy. Tumour Biol. 2012 Jan 26. [Epub ahead of print]
  34. Pucciarelli S, Rampazzo E, Briarava M, Maretto I, Agostini M, Digito M, Keppel S, Friso ML, Lonardi S, De Paoli A, Mescoli C, Nitti D, De Rossi A. Telomere-Specific Reverse Transcriptase (hTERT) and Cell-free RNA in Plasma as Predictors of Pathologic Tumor Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy. Ann Surg Oncol. 2012 Sep;19(9):3089-96
  35. Urso E, Agostini M, Pucciarelli S, Bedin C, D’angelo E, Mescoli C, Viel A, Maretto I, Nitti D. (2012). Soft tissue sarcoma and  the Hereditary Non Polyposis Colorectal Cancer (HNPCC) Syndrome: formulation of an hypothesis. Mol Biol Rep. 2012 Oct;39(10):9307-10.
  36. Cirillo L, Urso EDL, Parrinello G, Pucciarelli S, Moneghini D, Agostini M, Nitti D, Nascimbeni R. High risk of rectal cancer and of metachronous colorectal cancer in probandsof families fulfilling Amsterdam criteria. Ann Surg. 2012 Sep 10.
  37. Roman M, Jitaru P, Agostini M, Cozzi G, Pucciarelli S, Nitti D, Bedin C, Barbante C. Serum seleno-proteins status for colorectal cancer screening explored by data mining techniques - a multidisciplinary pilot study. (in press Microchemical Journal)
  38. Agostini M, Enzo MV, Bedin C, Belardinelli V, Goldin E, Del Bianco P, Maschietto E, D’Angelo E, Leo Izzi, Saccani A, Zavagno G, Nitti D. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients. Cancer Biomark. 2012;11(2-3):89-98.
  39. Mammano E, Galdi F, Pierobon M, Tessari E, Deng J, Pucciarelli S, Agostini M, De Marchi F, Canzonieri V, De Paoli A, Belluco     C, Liotta L, Petricoin E, Pilati P, Nitti D. Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment. Clin Colorectal Cancer. 2012 Dec;11(4):268-74.
  40. Pastò A, Marchesi M, Diamantini A, Frasson C, Curtarello M, Lago C, Pilotto G, Parenti AR, Esposito G, Agostini M, Nitti D, Amadori A. PKH26 Staining Defines Distinct Subsets of Normal Human Colon Epithelial Cells at Different Maturation Stages. PLoS One. 2012;7(8):e43379. Epub 2012 Aug 22.
  41. de Leon MP, Urso ED, Pucciarelli S, Agostini M, Nitti D, Roncucci L, Benatti P, Pedroni M, Kaleci S, Balsamo A, Laudi C, Di       Gregorio C, Viel A, Rossi G, Venesio T. Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. Tech Coloproctol. 2012 Sep 14. [Epub ahead of print]
  42. Pin E, Pastrello C, Tricarico R, Papi L, Quaia M, Fornasarig M, Carnevali I, Oliani C, Fornasin A, Agostini M, Maestro R, Barana D, Aretz S, Genuardi M, Viel A. MUTYH c.933+3A>C, associated with a severelyimpaired gene expression, is the first Italian   founder mutation in MUTYH-Associated Polyposis. Int J Cancer. 2013 Mar 1;132(5):1060-9.
  43. Urso EDL; Nascimbeni R, Pucciarelli S, Agostini M, Casella C, Moneghini D, Di Lorenzo D, Maretto I, Sullivan M, Mammi I, Viel A, Nitti D. Factors affecting the treatment of multiple colorectal adenomas. Surg Endosc. 2013 Jan;27(1):207-13.
  44. Lionello M, Blandamura S, Agostini M, Staffieri C, Lovato A, Tealdo G, Favaretto N, Giacomelli L, Loreggian L, Staffieri A, Marioni G. A prognostic role for Nm23-H1 in laryngeal carcinoma treated with postoperative radiotherapy: an introductory investigation. Eur Arch Otorhinolaryngol. 2013 Jan;270(1):197-203.
  45. Bertorelle R, Briarava M, Rampazzo E, Biasini L, Agostini M, Maretto I, Lonardi S, Friso ML, Mescoli C, Zagonel V, Nitti D, De Rossi A, Pucciarelli S. Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer. Br J Cancer. 2013 Jan 15. doi: 10.1038/bjc.2012.602.
  46. Agostini M, Bedin C, Enzo MV, Molin L, Traldi P, D’Angelo E, Maschietto E, Serraglia R, Ragazzi E, Prevedello L, Foletto M, Nitti D. Multivariate analysis approach to the serum peptide profile of morbidly obese patients. Dis Markers. 2013;34(4):269-  78. doi: 10.3233/DMA-130971.
  47. Zane M, Agostini M, Enzo MV, Casal Ide E,Del Bianco P, Torresan F, Merante Boschin I, Pennelli G, Saccani A, Rubello D, Nitti D, Pelizzo MR. Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAFV600E: A non-invasive tool panel for early detection of thyroid cancer. (in press Biomedicine & Pharmacotherapy 2013)
  48. Agostini M, Crotti S, Bedin C, Cecchin E, Maretto I, D'Angelo E, Pucciarelli S, Nitti D. Predictive response biomarkers in rectal cancer neoadjuvant treatment. Front Biosci (Schol Ed). 2014 Jan 1;6:110-9.
  49. Pasto A, Serafin V, Pilotto G, Lago C, Bellio C, Trusolino L, Bertotti A, Hoey T, Plateroti M, Esposito G, Agostini M, Nitti D, Amadori A, Indraccolo S. Notch3 signaling regulates musashi-1 expression in metastatic colorectal cancer cells. (in press Cancer Research).
  50. Kong A , Gupta C, Ferrari M, Agostini M, Bedin C, Bouamrani  A, Tasciotti E, Azencott R. Proteomic Signature Discovery From Mass Spectrometry Data. (in press Transactions on Computational Biology and Bioinformatics)

 

Marco Agostini

Research Scientist
Department of Oncology and Surgical Sciences 
University of Padova,  Padua, Italy
Phone: 0039-049-8214374 
E-mail: m.agostini@unipd.it